The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 28.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 52%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (4 analysts) rates it none, with a mean price target of $41.
CBIZ, Inc.
CBZ · the NYSE · USD · Market cap $3.0B · 9,500 employees
CBIZ, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-16
Screened 2026-09-16 · the tape above runs as of 15:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
CBIZ, Inc. holds its Accumulation at $54.60. The statistical read favours the sellers, held for 11 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the sellers, held for 11 days |
| Price at the screen | $54.60 |
| Valuation | 26.25 trailing · 12.85 forward price to earnings |
| Values screen | FAIL · score 64.7 |
| Beta | 0.92 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 41.47% | Below 33% | Interest-bearing debt is 41.5% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 11.06% | Below 49% | Money owed to the company is 11.1% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-16 screen. The gold marker is the market price at the same screen. A 0.7% margin of safety to the base estimate.
Third-party analyst targets: 3 covering, consensus None. The average target sits +1% from the screen price.
Reading the gap · Our model and the Street both land near today's price: fairly valued, with no strong edge either way.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-16 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsSteady services firm offers almost no upside
When a company grows revenue by just one percent a year, a forward earnings multiple of 9.4 times can look cheap without being cheap at all. CBIZ supplies accounting, tax and insurance services across the United States and Canada, yet the numbers show profit margins of six percent and return on equity of only eight percent.
Why we pass. Our fair value sits just six percent above the current price, which delivers no real margin of safety and earns an opportunity rating of none despite a clean ethical screen. Analyst targets hover around forty four dollars, but that still leaves little room once the slow top line is taken into account.
Risk sits in the modest returns and thin growth that could leave the shares drifting sideways for years. Low multiples on uninspiring businesses often prove to be value traps rather than bargains.
Analysis, not advice.
| Forward P/E | 12.9xreasonably valued |
| Trailing P/E | 26.3xa premium valuation |
| EPS, trailing | 2.08 |
| EPS, forward | 4.25 |
| Revenue growth | -0.2%revenue is shrinking |
| Profit margin | 4.4%barely profitable |
| Return on equity | 6.5%a modest return on shareholder capital |
| FCF yield | 8.12% |
| Debt to equity | 1.02a meaningful debt load worth watching |
| Current ratio | 1.47adequate liquidity, worth monitoring |
| Beta | 0.92steadier than the market |
| Short interest, float | 0.04% |
| 52-week range | 24.29 - 57.51 |
| Market cap | $3.0B |
| Employees | 9,500 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCBZ trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 25.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 52%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (4 analysts) rates it none, with a mean price target of $41.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 52%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (4 analysts) rates it none, with a mean price target of $41.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (65). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (65). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 6 Apr2026 | Josh Gottheimer | Democrat | buy | 1K–15K |
| 30 Jun2026 | Gil Cisneros | Democrat | sell | 1K–15K |
| 2026-04-06 | Josh Gottheimer | Democrat | Purchase | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $30.28 | +12.9% | · | $1,129 | +12.9% |
| 2 months | $27.03 | +26.5% | · | $1,265 | +26.5% |
| 3 months | $25.61 | +33.5% | · | $1,335 | +33.5% |
| 6 months | $53.75 | -36.4% | · | $636 | -36.4% |
| 1 year | $71.04 | -51.9% | · | $481 | -51.9% |
| 2 years | $74.34 | -54.0% | · | $460 | -54.0% |
| 3 years | $52.89 | -35.4% | · | $646 | -35.4% |
| 5 years | $32.90 | +3.9% | · | $1,039 | +3.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CBZ does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.